The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters.
about
Epstein-barr virus immediate-early protein BZLF1 is SUMO-1 modified and disrupts promyelocytic leukemia bodiesEpstein-Barr virus reactivation after superinfection of the BJAB-B1 and P3HR-1 cell lines with cytomegalovirus.Early events associated with infection of Epstein-Barr virus infection of primary B-cellsThe B-cell specific transcription factor, Oct-2, promotes Epstein-Barr virus latency by inhibiting the viral immediate-early protein, BZLF1Epstein-Barr virus immediate-early protein Zta co-opts mitochondrial single-stranded DNA binding protein to promote viral and inhibit mitochondrial DNA replication.Viral response to chemotherapy in endemic burkitt lymphomaEpstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinasesThe Epstein-Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein.Sumoylation of the Epstein-Barr virus BZLF1 protein inhibits its transcriptional activity and is regulated by the virus-encoded protein kinase.Function of the intercistronic region of BRLF1-BZLF1 bicistronic mRNA in translating the zta protein of Epstein-Barr virus.BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186.The Epstein-Barr virus R transactivator (Rta) contains a complex, potent activation domain with properties different from those of VP16.The Epstein-Barr virus BZLF1 protein inhibits tumor necrosis factor receptor 1 expression through effects on cellular C/EBP proteinsKaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains two functional lytic origins of DNA replicationUse of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.The effect of Epstein-Barr virus Latent Membrane Protein 2 expression on the kinetics of early B cell infectionInduction of the early growth response 1 gene by Epstein-Barr virus lytic transactivator Zta.The Epstein-Barr virus BRRF1 protein, Na, induces lytic infection in a TRAF2- and p53-dependent mannerEpithelial cell retention of transcriptionally active, P3HR-1-derived heterogeneous Epstein-Barr virus DNA with concurrent loss of parental virus.Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latencyThe Epstein-Barr virus (EBV) early protein EB2 is a posttranscriptional activator expressed under the control of EBV transcription factors EB1 and R.The Epstein-Barr virus latency BamHI-Q promoter is positively regulated by STATs and Zta interference with JAK/STAT activation leads to loss of BamHI-Q promoter activityThe Zif268 cellular transcription factor activates expression of the Epstein-Barr virus immediate-early BRLF1 promoter.YY1 binds to and regulates cis-acting negative elements in the Epstein-Barr virus BZLF1 promoter.Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 proteinActivation of the Epstein-Barr virus DNA polymerase promoter by the BRLF1 immediate-early protein is mediated through USF and E2F.Functional and physical interactions between the Epstein-Barr virus (EBV) proteins BZLF1 and BMRF1: Effects on EBV transcription and lytic replicationThe cellular YY1 transcription factor binds a cis-acting, negatively regulating element in the Epstein-Barr virus BRLF1 promoter.Late gene expression from the Epstein-Barr virus BcLF1 and BFRF3 promoters does not require DNA replication in cis.Unconventional processing of the 3' termini of the Epstein-Barr virus DNA polymerase mRNA.An Epstein-Barr Virus-Encoded Protein Complex Requires an Origin of Lytic Replication In Cis to Mediate Late Gene Transcription.Changing Epstein-Barr viral ZEBRA protein into a more powerful activator enhances its capacity to disrupt latencyThe cellular ataxia telangiectasia-mutated kinase promotes epstein-barr virus lytic reactivation in response to multiple different types of lytic reactivation-inducing stimuliViral genome methylation differentially affects the ability of BZLF1 versus BRLF1 to activate Epstein-Barr virus lytic gene expression and viral replication.RAZ, an Epstein-Barr virus transdominant repressor that modulates the viral reactivation mechanismFunctional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency.The Epstein-Barr virus immediate-early promoter BRLF1 can be activated by the cellular Sp1 transcription factorThe Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle.EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus.Regulation of the Epstein-Barr virus DNA polymerase gene.
P2860
Q24529499-A3B07250-DB6A-4746-8FEB-0EBFEA00172CQ24798984-BFCFD273-3B77-47C5-B6EC-7D9CAA783A0BQ28476230-1212D7B8-117B-42C5-8381-8C903F238320Q28480586-4D1D0493-5F75-4074-868A-336F22777B5DQ33321474-58F4BE6D-62B2-474C-8EEF-9F6DD23EF897Q33767066-3579BAD8-0E54-439B-88C1-13BC2DE70F9FQ33793163-0A99AF79-556B-46F3-8D1C-43F938F18943Q33817111-43CA8084-B67D-4CA1-BF6A-263C5F958829Q33826641-FBC18EA5-A250-434F-913A-94EDEB8823A8Q33836031-6D09F0B9-F8A9-44D3-A2B1-DCA3FE340353Q33843046-800E3004-1617-460D-8590-7C1EE0EBDE7BQ33936163-11316FCE-8634-4ACD-98E7-E7B1CAD341F0Q34291099-8E3D5149-33B0-4E52-AF4E-80B699DFB9BCQ34343562-44A3658E-6344-4F60-B94F-9027CFFDBEE8Q34350013-2BEBDBE7-1873-4BA2-B5A9-3B53390737F5Q34545445-F2EA84E0-A61F-40E5-AF77-0176124607ACQ35023745-4ED48449-6C32-43AB-A92D-946BB68C2BA9Q35076801-158DC33C-5895-400A-8689-B2AB65D6CC74Q35140295-80FA1BDA-44EE-4B90-B3A2-62DA7F067D2EQ35192797-B1D04E57-A7F1-4C14-B540-5E5CA6BCD369Q35537283-64CC4498-8755-4F44-8EEE-6B8CBA587E23Q35603820-4B5A74CE-B024-4AFC-B920-C4D702474A1CQ35839977-BF4ADC95-D4F2-4FC4-B112-9A64D924C915Q35841116-3AE488F8-FCFB-4B5C-9BA9-4B981AEB06CEQ35854017-AA9D047A-5973-43B9-9481-977401C929FEQ35859223-461524DB-C75A-4BC2-88BE-18E3B1AF7508Q35865903-115D11AF-1911-4580-90FE-3FADAB33BCB2Q35881644-60C50AAB-09EB-4F82-A773-62CB4CF22FD5Q35898898-A2ABE24F-56DB-4635-83E1-969FD3105EF7Q36050825-78AA9181-6CF0-4B08-BC93-E6DCAC86899CQ36062461-4EBBAD4B-B166-41FE-A6F5-B1F184B0CC0FQ36298743-4703EA57-DCF7-4D31-B92D-49206DEC7A5CQ36414572-8BB06941-6189-4270-92FC-FA500D2F588AQ36559479-C924042C-E1CD-4DF0-B52D-90CC4EA151ABQ36630074-0E386E80-E05E-42A2-B5ED-A49ED83293CFQ36648185-C37BA45B-508D-4AA7-AF12-F4EB5F574ABDQ36687270-4A79CBCE-5F05-4560-8054-6FC98D1F73F6Q36687455-CF86F211-EC1A-4B4C-A21A-6DF8BC308205Q36688330-3396CAD3-DF21-4D8C-B24E-328C489423D2Q36697341-5F49179A-6624-45A1-A37B-7CB5F4357AE6
P2860
The Epstein-Barr virus (EBV) BZLF1 immediate-early gene product differentially affects latent versus productive EBV promoters.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
1989年论文
@zh
1989年论文
@zh-cn
name
The Epstein-Barr virus (EBV) B ...... rsus productive EBV promoters.
@ast
The Epstein-Barr virus (EBV) B ...... rsus productive EBV promoters.
@en
type
label
The Epstein-Barr virus (EBV) B ...... rsus productive EBV promoters.
@ast
The Epstein-Barr virus (EBV) B ...... rsus productive EBV promoters.
@en
prefLabel
The Epstein-Barr virus (EBV) B ...... rsus productive EBV promoters.
@ast
The Epstein-Barr virus (EBV) B ...... rsus productive EBV promoters.
@en
P2093
P2860
P1433
P1476
The Epstein-Barr virus (EBV) B ...... rsus productive EBV promoters.
@en
P2093
P2860
P304
P407
P577
1989-04-01T00:00:00Z